Analysis and visualization of the course and burden over time of adverse drug reactions (ADRs) attributed to TNFα-inhibitors in patients with inflammatory rheumatic diseases (IRDs)-Reference-Cited by-同舟云学术

Analysis and visualization of the course and burden over time of adverse drug reactions (ADRs) attributed to TNFα-inhibitors in patients with inflammatory rheumatic diseases (IRDs)

Published:2022-08-10 Issue:3 Volume:22 Page:195-202
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

de Boer Merel¹^ORCID,Gosselt Helen R¹,Jansen Jurriaan¹,van Doorn Martijn B.A²³^ORCID,Hoentjen Frank⁴⁵,Nurmohamed Michael T⁶^ORCID,Spuls Phyllis I⁷,Tas Sander W⁸,Vonkeman Harald E⁹¹⁰^ORCID,Jessurun Naomi T¹^ORCID

Affiliation:

1. Netherlands Pharmacovigilance Centre Lareb, ’s-Hertogenbosch, the Netherlands

2. Department of Dermatology, Erasmus MC, Rotterdam, the Netherlands

3. Centre for Human Drug Research, Leiden, the Netherlands

4. Radboud University Medical Center, Nijmegen, the Netherlands

5. Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, AB, Canada

6. Amsterdam Rheumatology Immunology Center | Reade, Amsterdam, the Netherlands

7. Department of Dermatology, Amsterdam Public Health/Infection and Immunology, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, the Netherlands

8. Department of Rheumatology & Clinical Immunology, Amsterdam UMC, location AMC, University of Amsterdam and Amsterdam Rheumatology & Immunology Center (ARC), Amsterdam, the Netherlands

9. Department of Rheumatology and Clinical Immunology, Medisch Spectrum Twente, Enschede, the Netherlands

10. Department of Psychology, Health and Technology, University of Twente, Enschede, the Netherlands

Funder

Netherlands Organization for Health Research and Development

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2022.2110237

Reference22 articles.

1. How to meet patients' individual needs for drug information - a scoping review

2. Patients Perceptions of Medication Counselling from Community Pharmacies

3. Janssen Biologics B.V. Bijsluiter Remicade 100 mg poeder voor concentraat voor oplossing voor infusie.

4. AbbVie Biotechnology GmbH. Bijsluiter Humira 20 mg oplossing voor injectie in voorgevulde injectiespuit.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantification of longitudinal patient-reported burden of adverse drug reactions attributed to the use of TNF-α inhibitors in inflammatory rheumatic diseases: an observational prospective cohort study;Expert Opinion on Drug Safety;2024-08-30

2. The burden of adverse drug reactions reported by patients in the Dutch ADR monitor: a proof of concept;Expert Opinion on Drug Safety;2024-07-26